Filing Details
- Accession Number:
- 0001209191-17-011424
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-16 16:03:20
- Reporting Period:
- 2017-02-14
- Filing Date:
- 2017-02-16
- Accepted Time:
- 2017-02-16 16:03:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1337553 | Aerie Pharmaceuticals Inc | AERI | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1202090 | M Geoffrey Duyk | C/O Tpg Global, Llc 301 Commerce Street, Suite 3300 Fort Worth TX 76102 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-02-14 | 6,667 | $19.50 | 10,067 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-02-14 | 2,770 | $46.95 | 7,297 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2017-02-14 | 10,000 | $32.30 | 17,297 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-02-14 | 6,880 | $46.95 | 10,417 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2017-02-14 | 13,500 | $17.55 | 23,917 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-02-14 | 5,047 | $46.95 | 18,870 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2017-02-14 | 28,000 | $3.15 | 46,870 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-02-14 | 1,879 | $46.95 | 44,991 | No | 4 | F | Direct | |
Common Stock | Disposition | 2017-02-14 | 20,795 | $46.46 | 24,196 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-02-15 | 20,796 | $46.81 | 3,400 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2017-02-14 | 6,667 | $0.00 | 6,667 | $19.50 |
Common Stock | Stock Option (right to buy) | Disposition | 2017-02-14 | 10,000 | $0.00 | 10,000 | $32.30 |
Common Stock | Stock Option (right to buy) | Disposition | 2017-02-14 | 13,500 | $0.00 | 13,500 | $17.55 |
Common Stock | Stock Option (right to buy) | Disposition | 2017-02-14 | 28,000 | $0.00 | 28,000 | $3.15 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,333 | 2026-06-08 | No | 4 | M | Direct | |
0 | 2025-04-10 | No | 4 | M | Direct | |
0 | 2024-06-11 | No | 4 | M | Direct | |
0 | 2023-09-12 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $46.20 to $47.05, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $46.20 to $47.45, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- This option vested ratably on each of the first eight monthly anniversaries of June 8, 2016 and, subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, is scheduled to vest ratably on each of the following four monthly anniversaries of such date.
- This option vested ratably on each of the first 12 monthly anniversaries of April 10, 2015.
- This option vested fully on June 11, 2015.
- This option vested ratably on each of the first 36 monthly anniversaries of September 12, 2013.